August 28, 2026 Uncategorized BetterLife Pharma Inc. Announces Pricing of US$100 Million Public Offering of Common Shares and Pre-Funded Warrants Read More
August 27, 2026 Uncategorized BetterLife Pharma Appoints Charles Duncan as Director and Chair of the Audit Committee Read More
August 24, 2026 Uncategorized BetterLife Pharma Inc. Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants Read More
August 19, 2026 Uncategorized BetterLife Pharma Appoints Mahan Chehrenama, DO, as Chief Medical Officer Read More
